Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy)
Open Access
- 22 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 39 (12), 2387-2396
- https://doi.org/10.1007/s10096-020-03992-8
Abstract
Streptococcus agalactiae (also known Group B Streptococcus or GBS) represents the main pathogen responsible for early- and late-onset infections in newborns. The present study aimed to determine the antimicrobial susceptibility pattern and the capsular serotypes of GBS isolated in Eastern Sicily over 5 years, from January 2015 to December 2019. A total of 3494 GBS were isolated from vaginal swabs of pregnant women (37–39 weeks), as recommended by the Centers for Disease Control and Prevention. Capsular polysaccharide’s typing of GBS was determined by a commercial latex agglutination test containing reagents to serotypes I–IX. The antimicrobial resistance pattern of GBS was determined through the disk diffusion method (Kirby-Bauer) and the double-disk diffusion test on Mueller-Hinton agar plates supplemented with 5% defibrinated sheep blood, according to the guidelines of the Clinical and Laboratory Standards Institute. Serotypes III (1218, 34.9%) and V (1069, 30.6%) were the prevalent colonizers, followed by not typable (570, 16.3%) and serotypes Ia (548, 15.7%), Ib (47, 1.3%), II (40, 1.1%), and IV (2, 0.1%). All 3494 clinical isolates were susceptible to cefditoren and vancomycin. Resistance to penicillin, ampicillin, levofloxacin, clindamycin, and erythromycin was observed in 6 (0.2%), 5 (0.1%), 161 (4.6%), 1090 (31.2%), and 1402 (40.1%) of the strains, respectively. Most of erythromycin-resistant GBS (1090/1402) showed the cMLSB phenotype, 276 the M phenotype, and 36 the iMLSB phenotype. Our findings revealed a higher prevalence of serotype III and a relevant resistance rate, among GBS strains, to the most frequently used antibiotics in antenatal screening.Keywords
Funding Information
- Università degli Studi di Catania
This publication has 67 references indexed in Scilit:
- Novel Mutations in a Patient Isolate of Streptococcus agalactiae with Reduced Penicillin Susceptibility Emerging after Long-Term Oral Suppressive TherapyAntimicrobial Agents and Chemotherapy, 2011
- International External Quality Assurance for Laboratory Identification and Typing of Streptococcus agalactiae (Group B Streptococci)Journal of Clinical Microbiology, 2011
- Serotype Distribution and Invasive Potential of Group B Streptococcus Isolates Causing Disease in Infants and Colonizing Maternal-Newborn DyadsPLOS ONE, 2011
- Group B streptococcusserotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distributionBMC Infectious Diseases, 2010
- Genetic Heterogeneity in pbp Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- Point Mutation in the Group B Streptococcal pbp2x Gene Conferring Decreased Susceptibility to β-Lactam AntibioticsAntimicrobial Agents and Chemotherapy, 2008
- First Molecular Characterization of Group B Streptococci with Reduced Penicillin SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- Molecular Epidemiology and Distribution of Serotypes, Surface Proteins, and Antibiotic Resistance among Group B Streptococci in ItalyJournal of Clinical Microbiology, 2007
- Serotype IX, a Proposed New Streptococcus agalactiae SerotypeJournal of Clinical Microbiology, 2007
- Molecular Characterization of Nontypeable Group B StreptococcusJournal of Clinical Microbiology, 2006